Forvis Mazars Wealth Advisors’s Zimmer Biomet ZBH Stock Holding History

Forvis Mazars Wealth Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$389K	Buy	4,297 +20	+0.5%	+$1.83K	0.01%	321
2025 Q4	$385K	Sell	4,277 -46	-1%	-$4.36K	0.01%	318
2025 Q3	$426K	Sell	4,323 -7	-0.2%	-$694	0.01%	309
2025 Q2	$395K	Buy	4,330 +14	+0.3%	+$1.35K	0.01%	325
2025 Q1	$488K	Buy	+4,316	New	+$462K	0.01%	286
2024 Q3	–	Sell	-4,488	Closed	-$487K	–	443
2024 Q2	$487K	Buy	+4,488	New	+$529K	0.01%	296

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Forvis Mazars Wealth Advisors's ZBH Position: Q1 2026 in Review

Forvis Mazars Wealth Advisors increased its Zimmer Biomet (ZBH) stake by 0.47% in Q1 2026, buying an estimated $1.83K and bringing the position to 4,297 shares worth $389K. The position accounts for 0.01% of the portfolio, ranked #321.

Forvis Mazars Wealth Advisors first reported a position in ZBH in Q2 2024 and has held it in 6 quarters since. The position peaked at $488K in Q1 2025. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Forvis Mazars Wealth Advisors held 4,297 shares of Zimmer Biomet worth $389K as of Q1 2026.
Forvis Mazars Wealth Advisors bought 20 Zimmer Biomet shares in Q1 2026, an estimated $1.83K.
Zimmer Biomet made up 0.01% of Forvis Mazars Wealth Advisors's portfolio in Q1 2026, its #321 holding.
Forvis Mazars Wealth Advisors first reported a position in Zimmer Biomet in Q2 2024 and has held it in 6 quarters since.
Forvis Mazars Wealth Advisors's Zimmer Biomet position peaked at $488K in Q1 2025.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Forvis Mazars Wealth Advisors's 13F filing for Q1 2026, filed 1 May 2026.